Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

18F-FDG PET independently predicts survival in patients with HCC treated with 90Y microsphere radioembolization

Amir Sabet, Julien Bruhman, Torjan Haslerud, Hojjat Ahmadzadehfar, Carsten Meyer, Birgit Simon, Hans Biersack and Samer Ezziddin
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1479;
Amir Sabet
1Nuclear Medicine, University Hospital, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien Bruhman
1Nuclear Medicine, University Hospital, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Torjan Haslerud
1Nuclear Medicine, University Hospital, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hojjat Ahmadzadehfar
1Nuclear Medicine, University Hospital, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carsten Meyer
2Radiology, University Hospital, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Birgit Simon
2Radiology, University Hospital, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Biersack
1Nuclear Medicine, University Hospital, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samer Ezziddin
1Nuclear Medicine, University Hospital, Bonn, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1479

Objectives FDG-PET/CT is of prognostic value in patients with liver metastases undergoing radioembolization with 90Y microspheres (RE). However, for HCC the predictive role of PET has not yet been investigated in this setting. The aim was to evaluate pre- and post-therapeutic FDG PET/ CT for predicting survival in patients with unresectable HCC undergoing RE.

Methods We retrospectively analyzed a consecutive cohort of n=34 patients with non-resectable HCC undergoing RE (mean activity 1.8 GBq) with FDG-PET/CT pre- and 1 month post-treatment. According to the baseline FDG metabolic status of the HCC lesions, patients were divided into 2 groups: FDG-negative (n=14) and FDG-positive (n=20) patients. FDG-positive patients were separated to early metabolic responders and non-responders according to the post-treatment relative change of SUVmax in the treated lesions and of the tumor-to-liver ratio (T/L-R). Overall survival was analyzed with the Kaplan-Meier method (log-rank test, p<0.05).

Results The median overall survival (OS) after radioembolization was 13 months (95% CI, 11-15). FDG-negative patients had a significantly longer OS (19 mo, 95% CI 5-33) than FDG-positive patients (9 mo, 95% CI 6-11; p<0.001). Among FDG positive patients, metabolic responders survived significantly longer than non-responders (p=0.043). Out of the other baseline variables, only the tumor burden had a significant impact on overall survival in the univariate analysis (p=0.008). In the multivariate analysis, however, tumoral FDG status at baseline and post-treatment was the only independent predictor of survival (hazard ratio, 3.3 (95%CI 1.6-6.5); p< 0.001).

Conclusions Pre- and post-therapeutic FDG-PET independently predicts overall survival in patients with HCC undergoing radioembolization. The assessment of early metabolic response 1 month post-treatment allows significant risk stratification and may impact individualized treatment strategies.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET independently predicts survival in patients with HCC treated with 90Y microsphere radioembolization
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET independently predicts survival in patients with HCC treated with 90Y microsphere radioembolization
Amir Sabet, Julien Bruhman, Torjan Haslerud, Hojjat Ahmadzadehfar, Carsten Meyer, Birgit Simon, Hans Biersack, Samer Ezziddin
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1479;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET independently predicts survival in patients with HCC treated with 90Y microsphere radioembolization
Amir Sabet, Julien Bruhman, Torjan Haslerud, Hojjat Ahmadzadehfar, Carsten Meyer, Birgit Simon, Hans Biersack, Samer Ezziddin
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1479;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Time of Flight compared to standard iterative acquisition and reconstruction for assessment of pulmonary nodules.
  • Is childhood obesity linked to lymphoma?
  • Imaging characteristics of 18F-FDG PET/CT in patients with newly diagnosed angio-immunoblastic T cell lymphoma
Show more Oncology: Clinical Diagnosis

MTA I: GI - Colorectal & Liver Posters

  • Mathematical enhancement for detecting liver metastasis by FDG PET
  • 18F-FDG PET-CT in staging of intra-hepatic cholangiocarcinoma
  • The clinical utility of FDG-PET for patient with serum AFP elevation
Show more MTA I: GI - Colorectal & Liver Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire